Europe is one of the world’s leading regions for innovation in life sciences and healthcare biotechnology, often driven by life-saving breakthroughs from small and medium size enterprises. How can we better support these innovators and the value they bring to the science, research and innovation in Europe?
EuropaBio is currently conducting a survey among SMEs, venture capitalists, key opinion leaders, and biotech clusters to better understand the value of the current European IP incentives and rewards system. This invitation-only round-table will provide an opportunity to share and discuss the preliminary results of the survey and explore ways to safeguard Europe’s competitiveness in biotech innovation.
Venue: Brussels Press Club, Rue Froissart 95, 1000 Brussels, Belgium
For more information please contact Ronald Jager, Director for Healthcare Biotechnology at EuropaBio (r.jager@europabio.org).